focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

Share Price Information for Renold (RNO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.00
Bid: 55.40
Ask: 56.40
Change: 1.20 (2.19%)
Spread: 1.00 (1.805%)
Open: 55.60
High: 56.40
Low: 54.80
Prev. Close: 54.80
RNO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Awards - Performance Share Plan

7 Jun 2017 14:26

RNS Number : 4447H
Renold PLC
07 June 2017
 

Renold plc

("Renold" or "the Company")

 

GRANT OF AWARDS - PERFORMANCE SHARE PLAN

 

Renold announces that nil cost options (the "Awards") were granted on 5 June 2017 under the 2013 Performance Share Plan to the Executive Directors of the Company.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

The number of shares under the Awards was based on the average mid-market price for the preceding three days which was 54.79 pence.

The performance period applicable to the Awards is 1 April 2017 to 31 March 2020.

Robert Purcell (Chief Executive Officer)

 

Nil cost options over 1,095,090 shares were granted. The performance criteria for the vesting of the award is as follows. There are two performance targets.

 

EPS target attached to 50% of the award as follows:

 

Compound Annual Growth Rate in adjusted earnings per share ('adjusted EPS').

 

Entry level threshold - 25% of awards vest

10%

Maximum vesting - 100% of awards vest

15%

 

Between these two points the award vests on a linear basis. The starting measurement point is the adjusted EPS figure for the year ended 31 March 2017.

Provided that the minimum EPS target is achieved, a TSR target is attached to 50% of the award as follows:

 

TSR at the end of the Performance Period

% of Part B of Option that Vests

0%

83.9p

25%

Between 83.9p and 109.9p

25%-100% pro-rata

109.9p

100%

 

 

Ian Scapens (Group Finance Director)

Nil cost options over 337,653 shares were granted. The performance criteria for the vesting of the award is as follows:

 

Compound Annual Growth Rate in adjusted earnings per share ('adjusted EPS').

 

Entry level threshold - 25% of awards vest

10%

Maximum vesting - 100% of awards vest

15%

 

Between these two points the award vests on a linear basis. The starting measurement point is the adjusted EPS figure for the year ended 31 March 2017.

5 June 2017

ENQUIRIES:

Renold plc

0161 498 4500

Robert Purcell, Chief Executive Officer

 

Ian Scapens, Group Finance Director

 

 

 

Arden Partners

020 7614 5929

Chris Hardie

 

 

 

Instinctif

020 7457 2020

Mark Garraway

 

Helen Tarbet

 

NOTES FOR EDITORS

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

Further information about Renold can be found on its website at: www.renold.com

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robert Purcell

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Renold plc

b)

LEI

213800LNDGJY65SP6P54

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Nil cost options over Ordinary Shares of £0.05

 

ISIN: GB0007325078

 

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

Nil Cost Options

1,095,090

 

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

5 June 2017

f)

Place of the transaction

London Stock Exchange (XLON)

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ian Scapens

2

Reason for the notification

a)

Position/status

Group Finance Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Renold plc

b)

LEI

213800LNDGJY65SP6P54

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Nil cost options over Ordinary Shares of £0.05

 

ISIN: GB0007325078 

 

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

Nil Cost Options

337,653

 

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

5 June 2017

f)

Place of the transaction

London Stock Exchange (XLON)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUBUORBSANRAR
Date   Source Headline
5th Feb 202112:26 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSHolding(s) in Company
13th Jan 20217:00 amRNSTrading Update
17th Dec 20207:00 amRNSBlock listing Interim Review
26th Nov 20207:00 amRNSPreference Stock Dividend
23rd Nov 20204:15 pmRNSHolding(s) in Company
20th Nov 20207:00 amRNSAppointment of Non-Executive Director
18th Nov 20204:15 pmRNSHolding(s) in Company
16th Nov 20207:00 amRNSGrant of Awards – Performance Share Plan
11th Nov 20207:00 amRNSHalf-year Report
16th Oct 20207:00 amRNSTrading Update
1st Oct 20208:41 amRNSGrant of Awards - Performance Share Plan
24th Sep 20207:00 amRNSRe: Directorate Change
22nd Sep 20203:20 pmRNSDirector/PDMR Shareholding
18th Sep 20203:50 pmRNSDirector/PDMR Shareholding
11th Aug 20207:00 amRNSPDMR/Directorate Change
24th Jul 20201:23 pmRNSResult of AGM
24th Jul 20207:00 amRNSAGM Statement
26th Jun 20202:57 pmRNSAnnual Report and Accounts
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:37 pmRNSPrice Monitoring Extension
18th Jun 202010:37 amRNSDirector/PDMR Shareholding
18th Jun 20208:00 amRNSBlock listing Interim Review
17th Jun 202011:12 amRNSDirector/PDMR Shareholding
16th Jun 20207:00 amRNSFinal Results
28th May 20203:41 pmRNSHolding(s) in Company
27th May 20207:00 amRNSPreference Stock Dividend
12th May 20207:00 amRNSDirectorate Change
10th Mar 20207:00 amRNSDirector/PDMR Shareholding
2nd Mar 20202:21 pmRNSDirector/PDMR Shareholding
28th Feb 20207:00 amRNSTrading Update and Impact of Coronavirus
18th Dec 20197:00 amRNSBlock listing Interim Review
27th Nov 20197:00 amRNSPreference Stock Dividend
22nd Nov 20193:00 pmRNSGrant of Award - Performance Share Plan
18th Nov 20199:27 amRNSHolding(s) in Company
13th Nov 20197:00 amRNSDirectorate Changes
13th Nov 20197:00 amRNSHalf-year Report
30th Oct 201912:07 pmRNSSecond Price Monitoring Extn
30th Oct 201912:02 pmRNSPrice Monitoring Extension
14th Oct 20197:00 amRNSTrading Update
20th Sep 20194:58 pmRNSResult of AGM (replacement)
20th Sep 20192:07 pmRNSResult of AGM
27th Aug 20194:05 pmRNSRevised 2019 Annual Report and Accounts
27th Aug 20197:00 amRNSCompletion of investigation
21st Aug 201912:04 pmRNSHolding(s) in Company
17th Jul 20191:23 pmRNSAdjournment of Annual General Meeting 2019
12th Jul 20199:30 amRNSHolding(s) in Company
10th Jul 20199:10 amRNSDirector/PDMR Shareholding
9th Jul 20197:00 amRNSPostponement of Annual General Meeting
19th Jun 20197:00 amRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.